RNA interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapy. (Q37971100)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2012
edit
Language Label Description Also known as
English
RNA interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapy.
scientific article published on January 2012

    Statements

    RNA interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapy (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit